Levemax

Quick links to important sections

Levemax

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Levemax

Quick Facts

Property Description
Active Ingredient Levetiracetam (INN)
Pharmacological Class Antiepileptic Drug (AED) / Anticonvulsant
Origin Synthetic Pyrrolidine derivative
Available Forms Oral Tablet, Oral Solution, IV Injection
General Purpose To stabilize nerve activity and manage seizures

What Type of Medicine is Levemax?

Levemax is a specific prescription-only brand of medicine containing the active substance Levetiracetam. It is formally classified as a second-generation Antiepileptic Drug (AED), or anticonvulsant, used to stabilize abnormal electrical activity in the brain. The drug is a synthetic compound derived from the chemical structure known as a pyrrolidine derivative, which is pharmacologically distinct from older anticonvulsants.

Pharmacological studies confirm that Levetiracetam is a unique agent due to its action on the synaptic vesicle protein SV2A, giving it a high margin of safety and a favorable pharmacokinetic profile. This means the medicine works in a specific, targeted way that often results in fewer interactions with other drugs compared to older treatments.


Forms and Core Therapeutic Purpose

Levemax is a single-ingredient product available in multiple dosage forms, including the oral tablet, the oral solution, and a sterile solution for intravenous (IV) injection. This flexibility ensures that consistent control over nerve activity can be maintained, even when oral administration is temporarily not feasible. The oral and intravenous forms are considered bioequivalent, allowing for direct switching between routes.

This medication's fundamental purpose is to help control the occurrence and severity of seizures associated with epilepsy. It is commonly recognized as an effective option for partial-onset, myoclonic, and primary generalized tonic-clonic seizures. By stabilizing these signals in the brain, Levemax helps to prevent the rapid, uncontrolled electrical discharges that characterize seizure episodes.

Regulatory References

  1. Levetiracetam - LiverTox
  2. Levetiracetam Label - DailyMed

What side effects are possible with Levemax?

Possible Side Effects and Safety Information

Official regulatory documents classify the adverse effects of Levemax (Levetiracetam) by their frequency and the physiological system affected.

Commonly Documented Adverse Reactions

The most frequently reported adverse reactions, classified as Very Common (occurring in ge 1/10 patients) and Common (in ge 1/100 to < 1/10 patients) in official labeling, primarily involve the nervous system and general well-being.

Classification Examples of Reactions
Very Common Somnolence (drowsiness), headache, nasopharyngitis, asthenia (loss of strength), fatigue.
Common Dizziness, anxiety, depression, hostility, irritability, convulsion, lethargy, tremor, nausea, vomiting, diarrhea, and anorexia.

Serious Adverse Reactions and Safety Constraints

The official label documents serious safety concerns, which are typically rare but clinically significant. These include an increased risk of suicidal ideation and behavior associated with all antiepileptic medicines. Serious skin reactions are also documented, such as Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), Stevens-Johnson syndrome (SJS), and Toxic Epidermal Necrolysis (TEN).

Population and Timing Notes

Adverse effects such as drowsiness and fatigue are often reported to occur most frequently during the first month of treatment. For specific patient groups, the label notes that Levemax clearance is dependent on renal function, necessitating an adjustment to the dose for individuals with kidney impairment. Furthermore, the label states that the sudden cessation of the medicine must be avoided due to the documented risk of provoking an increase in seizure frequency.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Levemax (Levetiracetam) overdosage is centered on the risks associated with exaggerated central nervous system (CNS) effects. Documented presentations of acute overexposure include profound somnolence (drowsiness), along with behavioral changes such as agitation, hostility, and aggression. In severe cases, a significant decreased level of consciousness is documented, which may progress to respiratory depression and a state of coma. Other observed clinical signs include coordination abnormalities.


Required Emergency Action

Regulatory authorities mandate that any individual with a suspected Levemax overdose must seek immediate medical attention. Guidance requires contacting emergency services or a certified Poison Control Center for immediate assistance. Management is strictly defined as symptomatic and supportive, and official labeling confirms that no specific antidote is known. A significant fraction of the drug can be removed via hemodialysis, establishing this as a documented procedural intervention for severe overdosage. Patients with existing renal impairment are noted to be at increased risk of prolonged toxicity due to the drug's reliance on renal clearance.

Therapeutic Uses of Levemax

What Levemax Treats: Main Uses and Benefits

This medication is commonly used to help with the management of symptoms associated with acute or episodic changes, particularly in conditions where functional stability becomes affected, such as those involving symptoms of increased neurological or muscular activity. It is applied across domains where additional symptomatic support is needed.

Levemax is generally relevant for managing intense and disruptive symptom clusters that interfere with daily comfort. It is considered relevant in conditions characterized by periods of heightened symptoms or recurrent manifestations. The medication supports the patient during difficult episodes by easing distress. It provides support that helps ease the overall symptom burden, contributing to improved day-to-day comfort during symptomatic periods.

Quick Fact: Relevant for Symptoms of Increased Neurological Activity

Regulatory References

  1. Levetiracetam: MedlinePlus Drug Information

Eligibility and Restrictions for Use

The eligibility for Levemax (levetiracetam) is defined by official regulatory criteria, primarily concerning age, organ function, and known allergies.

Who Cannot Use Levemax (Contraindications)

Category Restriction Official Classification
Hypersensitivity Patients with a known allergy to levetiracetam or any other pyrrolidone derivatives must not use the medicine. Absolute Contraindication

Age- and Condition-Based Restrictions

Levemax is approved for use across a wide age range, but limitations apply based on the specific type of treatment and the patient's physiological status:

  • Adjunctive Therapy: Eligible for adults, adolescents, children, and infants starting from 1 month of age for partial-onset seizures.
  • Monotherapy: Only approved for adults and adolescents 16 years and older. Use in younger children for monotherapy is not formally established in regulatory labeling.
  • Renal Impairment: Eligibility is conditional on the patient's kidney function. Since the drug is mainly cleared by the kidneys, individuals with impaired renal function require an individualized dose adjustment as mandated by the labeling, including older adults who may have age-related renal decline.
  • Pregnancy and Lactation: Use during pregnancy is permitted only if clearly needed, and the potential benefit outweighs the risk. Lactating women are generally not recommended to breastfeed due to drug excretion into human milk.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Levemax (levetiracetam) is considered minimal, primarily due to its unique metabolic pathway. The substance is not significantly metabolized by the major liver cytochrome P450 (CYP) enzyme systems, which minimizes the potential for many common pharmacokinetic drug-drug interactions.

However, regulatory documents outline specific interaction patterns:

Pharmacokinetic and Exposure Interactions

Interacting Class Documented Effect on Levemax Basis of Interaction
Enzyme-Inducing AEDs (e.g., Carbamazepine, Phenytoin) Increases Levemax apparent clearance (approx. 22%), potentially lowering plasma levels. Pharmacokinetic alteration

Pharmacodynamic and Substance Interactions

Central Nervous System (CNS) Depressants Co-administration with other medicines that cause sedation, such as benzodiazepines or opioids, may lead to additive CNS effects, including increased drowsiness, fatigue, and somnolence. Official labeling notes this potential for combined effects on the central nervous system.

Food and Alcohol Levemax can be administered with or without food, as food does not significantly affect the overall drug exposure. While no specific interaction data with alcohol is available in all regulatory documents, the PD caution applies, as alcohol is a CNS depressant.

Population-Specific Note The drug’s apparent body clearance is correlated with creatinine clearance, which requires that changes in kidney function (renal impairment) be considered as a factor affecting the drug's elimination from the body.

Mechanism of Action

Modulating Presynaptic Neurotransmitter Release

Levetiracetam's core mechanism involves high-affinity binding to the Synaptic Vesicle Protein 2A (SV2A), an integral protein found on presynaptic vesicles. This interaction functionally modulates synaptic exocytosis, the process by which nerve cells release messengers, resulting in a reduction of excitatory signaling.

Inhibiting Neuronal Hypersynchronization

By limiting the release of excitatory neurotransmitters, Levetiracetam dampens the rapid, simultaneous electrical discharges that characterize neuronal hypersynchronization. This action, supported by the partial influence on voltage-gated calcium channels, directly impedes the propagation of abnormal electrical signals across neural circuits, modifying the propagation of neural signals.

Mechanism Selectivity and Specificity

The drug's mechanism is characterized by its selective influence on overactive or dysregulated neural firing, largely sparing normal, necessary signaling. The mechanism influences the functional selectivity toward dysregulated neural firing by suppressing only the excessive electrical activity, without significant functional impairment of routine neural signaling.

Dosage and Administration Information

How Levemax is Used: Official Administration Guidelines

Levemax (levetiracetam) is administered via two approved routes: oral (tablets or solution) and intravenous (IV) infusion. The total daily dose and frequency must remain equivalent when switching between oral and IV forms, with the IV route reserved for when oral administration is temporarily not feeasible.

Standard Dosing and Titration

For adults and adolescents weighing 50 kg or more, the typical regimen involves twice-daily dosing (every 12 hours) and can be taken with or without food.

Administration Parameter Adult (≥ 50 kg) Instruction
Starting Daily Dose 1000 mg total (500 mg twice daily)
Dose Titration Increase by 1000 mg/day (500 mg twice daily) every two weeks
Maximum Daily Dose 3000 mg total (1500 mg twice daily)

Special Procedural Instructions

For the intravenous infusion, the prescribed dose must be administered slowly over a 15-minute IV infusion period. If using the oral solution, it must be accurately measured with a calibrated device, and may be mixed in a glass of water before intake. Tablets are generally swallowed whole.

Population Adjustments and Duration

Dosing must be reduced for patients with impaired renal function (kidney problems) because the medicine is eliminated by the kidneys. These adjustments are individualized based on creatinine clearance calculations. In pediatric patients, dosing is weight-based and the oral solution is often recommended, especially for children weighing less than 25 kg. Treatment, when discontinued, must be withdrawn gradually (tapered) over several weeks to avoid abrupt cessation, which is a key instruction for long-term use.

Recent Clinical Evidence

Overview of Clinical Evidence for Seizure Syndromes

Research on Levemax is primarily supported by multiple short-term, randomized, placebo-controlled trials (RCTs). These studies evaluated the medicine as an add-on therapy for managing focal (partial-onset) seizures in a broad population spanning adults, adolescents, and children (down to one month old). The findings consistently reported measurements indicating a measured difference in weekly seizure frequency between the study group and the placebo group. Similar high-quality controlled trials have also examined the medicine’s use in treating generalized seizure syndromes, specifically myoclonic seizures and primary generalized tonic-clonic seizures (pGTCS). This research focused on tracking and measuring the difference in the frequency of these seizure types during the trial period.

Research on Acute Intravenous Use

The intravenous (IV) formulation of Levemax was evaluated in acute care settings addressing prolonged seizure episodes (status epilepticus). The evidence for this use is based on systematic reviews and comparative studies that monitored the rate of clinical seizure cessation. Findings describe group patterns regarding the observed cessation rate compared to data for other IV treatments. Due to the nature of emergency research, the evidence quality varies across studies, and certainty regarding its optimal role in acute protocols remains low.

Limitations and Key Evidence Gaps

While evidence is well-documented for its role as an add-on therapy, data for using Levemax as the single, first-line medicine (monotherapy) is less numerous than for adjunctive use. Furthermore, the follow-up durations were limited in the pivotal controlled trials. Consequently, long-term data concerning sustained symptom control and durability of response over many years are mainly derived from observational extension studies, which lack control groups.

Frequently Asked Questions (FAQ)

Common questions about Levemax (FAQ)

Q: How long does it usually take for Levemax to start working?

Studies and official information indicate that the effectiveness of the medication is typically measured over a period of weeks during clinical trials. The purpose of the medicine is to stabilize nerve activity over time. It is common for related adverse effects, such as drowsiness and fatigue, to be reported most frequently during the first month of treatment.

Q: Do people typically feel an immediate effect after taking Levemax?

The medication is intended to stabilize abnormal electrical activity in the brain to help control seizures. According to official information, the effect is primarily measured by a reduction in seizure frequency over time, rather than an immediate change in sensation or feeling.

Q: What should I know about the long-term use of Levemax?

The drug is often used for the long-term management of chronic conditions like epilepsy. Official clinical guidance describes that discontinuation requires gradual tapering over several weeks. Long-term safety and sustained effects have been examined in observational studies.

Q: What is the typical timeframe for someone to be on Levemax therapy?

The medication is approved for managing chronic conditions such as epilepsy. According to official documents, it is generally used to control seizures for as long as treatment is required, rather than being limited to a fixed temporary period.

Q: Can Levemax cause feelings of dizziness or drowsiness?

Yes, official documents list somnolence (drowsiness), fatigue, and dizziness as very common or common adverse reactions. These effects are particularly frequent during the first month of treatment, as noted in the official product information.

Q: What if I experience a rare side effect mentioned in official documents?

Official labeling documents serious but rare adverse reactions, such as severe skin conditions (e.g., Stevens-Johnson syndrome). Safety warnings indicate that immediate medical attention is necessary if symptoms such as a severe rash, fever, or swelling of the face are noticed.

Q: Does Levemax affect a person's ability to drive?

The medication may cause dizziness, drowsiness, and problems with coordination. Official warnings describe that patients should avoid driving or operating hazardous machinery until they understand how the medicine affects their level of alertness and motor skills.

Q: Does Levemax interact with alcohol?

Official documents note that caution is described in the context of alcohol use. Alcohol is a Central Nervous System (CNS) depressant and may cause additive effects when combined with the medication, potentially leading to increased drowsiness and fatigue.

Q: Is it common for Levemax to cause headaches?

Yes, headache is classified as a very common adverse reaction in official documents. This means that, based on clinical trial data, it may affect 1 in 10 patients or more.

Q: What are common user experiences reported about the onset of Levemax?

The purpose of the medicine is to stabilize nerve activity in the brain. According to regulatory sources, the most frequently reported CNS-related side effects, such as drowsiness and fatigue, are typically observed during the first month of treatment.

Q: Is Levemax considered a controlled substance?

No, the medication is classified as an antiepileptic drug. It is not scheduled under the Controlled Substances Act, as it is officially recognized as having no significant potential for abuse or physical dependence.

Q: Is Levemax suitable for use in children?

Yes, the drug is approved as an add-on therapy for certain types of seizures in pediatric patients. The minimum approved age depends on the seizure type and formulation, with approvals ranging from infants (IV) to children 4 years and older (oral) for specific uses.

Q: Does Levemax have any known interactions with herbal supplements?

Official interaction data is limited for many specific herbal supplements. Official documents indicate a need for caution when using any supplement that can cause drowsiness or sedation, due to the potential for additive effects on the central nervous system.

Q: What happens if I miss a dose of Levemax?

Official patient information describes the recommended approach for a missed dose. It states that if a dose is missed, taking it as soon as it is remembered is described. However, if it is almost time for the next scheduled dose, official guidance indicates the missed dose is skipped to prevent taking doses too close together.

Q: Is Levemax used to treat temporary conditions or long-term ones?

The medication is primarily indicated for the long-term management of chronic conditions like epilepsy. It is used to help control seizures for the duration of the required treatment period.

Q: How is Levemax classified by major health organizations?

The medication is officially classified as a second-generation Antiepileptic Drug (AED). It is recognized globally and is included on the World Health Organization’s (WHO) Model List of Essential Medicines.

Q: Is Levemax the same as the drug 'Levetone'?

Levemax is a specific brand name for the active ingredient Levetiracetam. While the active ingredient may be sold under various brand names, official regulatory documents do not list 'Levetone' among the primary recognized brand names in the United States.

Q: Can I drink coffee or caffeine while taking Levemax?

Official documents describe the need for caution regarding the excessive consumption of caffeine. Caffeine is a stimulant that may potentially interfere with the drug's antiepileptic action and increase the risk of seizures in certain individuals.

Q: Are there special precautions for athletes who use Levemax?

The medicine is generally permitted under the World Anti-Doping Code (WADC). However, official guidance indicates that due to its properties, athletes in certain regulated sports may be required to obtain a Therapeutic Use Exemption (TUE) before use.

Q: How is Levemax related to the body's natural chemicals?

The medicine works by binding to a protein in the brain called Synaptic Vesicle Protein 2A (SV2A). This action is described as modulating the process by which nerve cells release neurotransmitters (the body's chemical messengers) to reduce excessive signaling.

Q: Can Levemax be taken with a multivitamin?

No clinically significant interactions have been documented between this medication and common multivitamins. Regulatory documents reflect that interactions are minimal due to the drug's unique metabolic profile.

Q: Is Levemax known to interact with blood pressure medications?

Official labeling documents do not list common blood pressure medications as having a clinically significant pharmacokinetic interaction. The drug's unique metabolic pathway minimizes many common drug-drug interactions.

Q: What is the shelf life of Levemax?

The stability of the medication when unopened and stored correctly is described in the product labeling. For oral tablets, the shelf life is often documented as 36 months from the date of manufacture.

Q: What evidence exists for Levemax use in different patient groups?

Clinical evidence documents the drug's role as an add-on therapy for multiple seizure types across various age groups, including adults, adolescents, and children. Separate studies address its safety and specific dosing requirements in pediatric and elderly populations.

Q: Can Levemax cause skin rash or sensitivity to sunlight?

Official documentation notes the possibility of serious, rare skin reactions (like Stevens-Johnson syndrome). While a general skin rash is listed as a rare potential adverse event, official labeling does not commonly list sensitivity to sunlight as a documented side effect.

Q: What type of doctor usually prescribes Levemax?

Although any licensed practitioner may prescribe the drug, the medication is typically prescribed and managed by specialists experienced in the treatment of epilepsy. This often includes neurologists.

Q: Why is Levemax sometimes prescribed instead of alternative treatments?

The drug is often chosen due to its unique mechanism of action on the SV2A protein. Official sources highlight its favorable pharmacokinetic profile and minimal interaction profile with many other medicines, which is often cited in the context of its use.

Q: What kind of studies support the claims made about Levemax?

The claims are supported primarily by evidence from short-term, randomized, placebo-controlled trials (RCTs). These studies examined the drug as an add-on therapy and are supplemented by longer-term observational studies.

Q: Is there a generic version of Levemax available?

Yes, the active ingredient in Levemax is Levetiracetam, which is widely available in generic form. The generic product is considered bioequivalent to the brand-name medication.

Q: What are the typical conditions for discontinuing Levemax?

Discontinuation decisions are made by a healthcare provider. Immediate discontinuation may be necessary if a patient develops a serious adverse reaction, such as a severe skin condition. Otherwise, official guidance describes that treatment requires gradual tapering.

Q: How long does Levemax stay in the system?

In healthy adults, the elimination half-life is typically about 7 pm 1 hours. Based on pharmacokinetics, it takes approximately 44 hours for the drug to be considered fully cleared from the body.

Q: Do regulatory bodies classify Levemax as a high-risk medication?

Regulatory bodies classify the overall risk profile based on its use and mandate the inclusion of specific warnings. These warnings highlight the potential for serious risks such as suicidal thoughts and severe skin reactions. It is not classified as a controlled substance.

Q: How does Levemax affect people who have liver conditions?

The medication is primarily eliminated by the kidneys and is not extensively metabolized by the liver’s major enzyme systems. Official documents therefore state that a dose adjustment is typically not necessary for patients with liver impairment, unlike those with kidney impairment.

Q: What are the official warnings about Levemax?

Official warnings and precautions highlight the potential for suicidal thoughts and behavior, the risk of behavioral abnormalities (such as agitation or aggression), the occurrence of serious skin reactions (e.g., DRESS, SJS), and potential changes in blood cell counts.

Q: What information is available about Levemax use during pregnancy?

Official labeling notes that physiological changes during pregnancy may gradually decrease plasma levels of the medication. The documentation describes the importance of careful patient monitoring throughout pregnancy and continuing through the postpartum period.

Q: Are there guidelines for using Levemax while breastfeeding?

Official labeling indicates the active ingredient is known to be excreted into human milk. The documentation describes that the potential risks to the child must be considered, and official guidance emphasizes the need for a healthcare provider’s input.

How should Levemax be stored and disposed of?

How to Store and Dispose of Levetiracetam (Levemax)

Official Storage Conditions

Oral forms of this medication must be stored at controlled room temperature, typically 20 C to 25 C. The container must be kept tightly closed and stored away from light, excessive heat, and moisture. Storage in environments such as the bathroom is prohibited. All forms of Levemax must be kept out of the sight and reach of children, requiring the use of locked safety caps and placement in an up and away location, as defined by regulatory labeling.

Stability and Disposal

The intravenous solution, once diluted for infusion, has a limited stability period and should be used within four hours at room temperature, or up to 24 hours if refrigerated. For unused or expired product, the official disposal protocol recommends using a drug take-back program. If this is unavailable, the medicine should be mixed with an undesirable substance (such as dirt) and placed in a sealed container for the trash; Levetiracetam is not on the FDA's flush list.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Levemax found in:

A-Z Index: